AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
University of California, Davis · Sorbonne Université · +14 more institutions
Abstract
WHAT'S NEW SINCE THE 2010 GUIDELINES? Inclusion of guidance for the diagnosis and management of cholangiocarcinoma (CCA) in patients with and without primary sclerosing cholangitis (PSC) (Figures 5, 8, and 9). Introduction of the term relevant stricture, defined as any biliary stricture of the common hepatic duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis (Table 1). In patients with equivocal MRI with cholangiopancreatography (MRI/MRCP) findings, a repeated high‐quality MRI/MRCP should be performed for diagnostic purposes. Endoscopic retrograde cholangiopancreatography (ERCP) should be avoided for the diagnosis of PSC (Figure 2). In patients with…
Citation impact
- FWCI
- 57.80
- Percentile
- 100%
- References
- 522
Authors
12- CLChristopher L. BowlusCorresponding
University of California, Davis
- LALionel Arrivé
Sorbonne Université, Hôpital Saint-Antoine
- ABAnnika Bergquist
Karolinska University Hospital, Karolinska Institutet
- MDMark Deneau
University of Utah
- LFLisa Forman
University of Colorado Anschutz Medical Campus, University of Colorado Denver
Topics & keywords
- Primary sclerosing cholangitis
- Medicine
- General surgery
- Internal medicine
- Gastroenterology
- Disease
- Good health and well-being